The_DT
interleukin-8_NN
AP-1_NN
and_CC
kappa_NN
B-like_JJ
sites_NNS
are_VBP
genetic_JJ
end_NN
targets_NNS
of_IN
FK506-sensitive_JJ
pathway_NN
accompanied_VBN
by_IN
calcium_NN
mobilization_NN
._.

FK506_NN
,_,
an_DT
immunosuppressant_NN
,_,
inhibits_VBZ
the_DT
production_NN
of_IN
several_JJ
cytokines_NNS
in_IN
T_NN
lymphocytes_NNS
._.

We_PRP
observed_VBD
that_IN
FK506_NN
suppressed_VBD
the_DT
transcription_NN
of_IN
a_DT
chemotactic_JJ
cytokine_NN
,_,
interleukin-8_NN
-LRB-_-LRB-
IL-8_NN
-RRB-_-RRB-
in_IN
a_DT
human_JJ
T_NN
cell_NN
line_NN
,_,
Jurkat_NN
cells_NNS
,_,
activated_VBN
by_IN
phorbol_NN
12-myristate_NN
13-acetate_NN
-LRB-_-LRB-
PMA_NN
-RRB-_-RRB-
and_CC
calcium_NN
-LRB-_-LRB-
Ca2_NN
+_NN
-RRB-_-RRB-
ionophore_NN
-LRB-_-LRB-
ionomycin_NN
-RRB-_-RRB-
._.

By_IN
deleted_VBN
and_CC
mutated_VBN
analysis_NN
of_IN
the_DT
IL-8_NN
promoters_NNS
,_,
the_DT
AP-1_NN
and_CC
kappa_NN
B-like_JJ
sites_NNS
were_VBD
identified_VBN
as_IN
the_DT
responsive_JJ
elements_NNS
for_IN
PMA_NN
and_CC
ionomycin_NN
._.

FK506_NN
suppressed_VBD
the_DT
transcriptions_NNS
through_IN
the_DT
AP-1_NN
or_CC
kappa_NN
B-like_JJ
sites_NNS
induced_VBN
by_IN
PMA_NN
plus_CC
Ca_NN
-LRB-_-LRB-
2_CD
+_NN
-RRB-_-RRB-
-_:
mobilizing_JJ
agents_NNS
,_,
but_CC
not_RB
those_DT
induced_VBN
by_IN
Ca_NN
-LRB-_-LRB-
2_CD
+_NN
-RRB-_-RRB-
-_:
independent_JJ
stimuli_NNS
._.

In_IN
gel_NN
retardation_NN
analysis_NN
,_,
FK506_NN
had_VBD
little_JJ
effect_NN
on_IN
the_DT
binding_NN
to_TO
the_DT
AP-1_NN
site_NN
of_IN
PMA\/ionomycin-induced_JJ
nuclear_JJ
factors_NNS
,_,
which_WDT
were_VBD
recognized_VBN
with_IN
anti-JunD_NN
or_CC
c-Fos_NN
antibody_NN
._.

In_IN
contrast_NN
,_,
FK506_NN
or_CC
EGTA_NN
-LRB-_-LRB-
Ca2_NN
+_CC
chelator_NN
-RRB-_-RRB-
similarly_RB
affected_VBD
the_DT
formation_NN
of_IN
kappa_NN
B-like_JJ
site_NN
binding_NN
complexes_NNS
,_,
which_WDT
were_VBD
not_RB
recognized_VBN
by_IN
any_DT
antibodies_NNS
against_IN
the_DT
human_JJ
Rel_NN
family_NN
proteins_NNS
-LRB-_-LRB-
c-Rel_NN
,_,
p65_NN
,_,
p50_NN
,_,
and_CC
p49_NN
-RRB-_-RRB-
._.

Furthermore_RB
,_,
we_PRP
confirmed_VBD
the_DT
previous_JJ
report_NN
that_IN
FK506_NN
suppressed_VBD
the_DT
PMA\/ionomycin-induced_JJ
activation_NN
through_IN
authentic_JJ
kappa_NN
B_NN
site_NN
of_IN
immunoglobulin_NN
-LRB-_-LRB-
Ig_NN
-RRB-_-RRB-
gene_NN
,_,
to_TO
which_WDT
NF-kappa_NN
B_NN
binding_NN
was_VBD
also_RB
decreased_VBN
by_IN
FK506_NN
,_,
indicating_VBG
that_IN
both_CC
IL-8_NN
kappa_NN
B-like_JJ
site_NN
and_CC
Ig_NN
kappa_NN
B_NN
site_NN
are_VBP
FK506-sensitive_JJ
in_IN
spite_NN
of_IN
the_DT
difference_NN
of_IN
binding_VBG
factors_NNS
._.

Our_PRP$
results_NNS
indicate_VBP
that_IN
not_RB
only_RB
the_DT
reported_VBN
IL-2_NN
NF-AT_NN
and_CC
NFIL-2A_NN
sites_NNS
and_CC
Ig_NN
kappa_NN
B_NN
site_NN
,_,
but_CC
also_RB
the_DT
IL-8_NN
AP-1_NN
and_CC
kappa_NN
B-like_JJ
sites_NNS
are_VBP
terminals_NNS
of_IN
FK506-sensitive_JJ
pathway_NN
involving_VBG
Ca2_NN
+_CC
mobilization_NN
._.

